RELAX SERELAXIN TRIAL PROGRAM Trademark

Trademark Overview

On Wednesday, March 12, 2014, a trademark application was filed for RELAX SERELAXIN TRIAL PROGRAM with the United States Patent and Trademark Office. The USPTO has given the RELAX SERELAXIN TRIAL PROGRAM trademark a serial number of 86218574. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 14, 2018. This trademark is owned by Novartis AG. The RELAX SERELAXIN TRIAL PROGRAM trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Providing medical and scientific research information in the field of pharmaceuticals and clinical trials featuring serelaxin; conducting clinical trials for others featuring serelaxin; all aforementioned services relating to cardiovascular diseases and disorders featuring serelaxin

Providing medical information, namely, clinical study results to doctors and patients relating to cardiovascular diseases and disorders featuring serelaxin
relax serelaxin trial program

General Information

Serial Number86218574
Word MarkRELAX SERELAXIN TRIAL PROGRAM
Filing DateWednesday, March 12, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 14, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 10, 2015

Trademark Statements

Indication of Colors claimedThe color(s) purple, white, orange, green, turquoise, yellow, and light green is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text"SERELAXIN TRIAL PROGRAM"
Description of MarkThe mark consists of the following: several lines that form a hyperbolic paraboloid above the word "RELAX" followed by the words "SERELAXIN TRIAL PROGRAM" presented in three lines, the lines of the hyperbolic paraboloid gradually change from purple and white, to turquoise and white, to green and white, to yellow and white, and then to orange and white from left to right, and the words "RELAX SERELAXIN TRIAL PROGRAM" are light green.
Goods and ServicesProviding medical and scientific research information in the field of pharmaceuticals and clinical trials featuring serelaxin; conducting clinical trials for others featuring serelaxin; all aforementioned services relating to cardiovascular diseases and disorders featuring serelaxin
Goods and ServicesProviding medical information, namely, clinical study results to doctors and patients relating to cardiovascular diseases and disorders featuring serelaxin

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, March 25, 2014
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, March 25, 2014
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events

Event DateEvent Description
Monday, May 14, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, May 14, 2018ABANDONMENT - NO USE STATEMENT FILED
Saturday, October 7, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 6, 2017EXTENSION 5 GRANTED
Sunday, October 1, 2017EXTENSION 5 FILED
Friday, October 6, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sunday, October 1, 2017TEAS EXTENSION RECEIVED
Tuesday, April 4, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, April 2, 2017EXTENSION 4 GRANTED
Sunday, April 2, 2017EXTENSION 4 FILED
Sunday, April 2, 2017TEAS EXTENSION RECEIVED
Saturday, October 29, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 28, 2016EXTENSION 3 GRANTED
Tuesday, October 4, 2016EXTENSION 3 FILED
Tuesday, October 4, 2016TEAS EXTENSION RECEIVED
Tuesday, May 10, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 9, 2016EXTENSION 2 GRANTED
Friday, April 1, 2016EXTENSION 2 FILED
Tuesday, May 3, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, April 1, 2016TEAS EXTENSION RECEIVED
Tuesday, October 6, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 2, 2015EXTENSION 1 GRANTED
Friday, October 2, 2015EXTENSION 1 FILED
Friday, October 2, 2015TEAS EXTENSION RECEIVED
Tuesday, April 7, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 10, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 10, 2015PUBLISHED FOR OPPOSITION
Wednesday, January 21, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, January 5, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, January 5, 2015ASSIGNED TO LIE
Wednesday, December 17, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 16, 2014EXAMINER'S AMENDMENT ENTERED
Tuesday, December 16, 2014NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, December 16, 2014EXAMINERS AMENDMENT E-MAILED
Tuesday, December 16, 2014EXAMINERS AMENDMENT -WRITTEN
Monday, December 8, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 8, 2014NON-FINAL ACTION E-MAILED
Monday, December 8, 2014NON-FINAL ACTION WRITTEN
Monday, November 17, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 17, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 17, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 24, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 24, 2014NON-FINAL ACTION E-MAILED
Tuesday, June 24, 2014NON-FINAL ACTION WRITTEN
Monday, June 16, 2014ASSIGNED TO EXAMINER
Wednesday, March 26, 2014NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, March 25, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, March 15, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

program trial serelaxin relax featuring clinical disorders medical providing trials cardiovascular information relating